Discover 2,163 paid clinical trials in Carlsbad, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,163
A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
for
Major Depressive Disorder (MDD)
Location: Costa Mesa CA, Bellflower CA, Phoenix AZ, Lafayette CA,
Sponsor: Draig Therapeutics Ltd
Sex: All
Age: 18 - 70+
Code: NCT07610473
Phase 2, Recruiting
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
for
Muscle Invasive Bladder Urothelial Carcinoma,
Location: Irvine CA, Corona CA, Upland CA, Duarte CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT07061964
Phase 2, Recruiting
Different Types of Massage Therapy to Reduce Anxiety During Chemotherapy Infusion in Patients With Cancer
for
Hematopoietic and Lymphatic System Neoplasm,
Location: Irvine CA
Sponsor: City of Hope Medical Center
Sex: All
Age: 18+
Code: NCT07184294
Recruiting
Neoadjuvant Botensilimab and Balstilimab for the Treatment of Advanced Resectable Colorectal Cancer NEST3
for
Advanced Colon Adenocarcinoma,
Location: Irvine CA, Corona CA, Huntington Beach CA,
Sponsor: City of Hope Medical Center
Sex: All
Age: 18+
Code: NCT07595874
Phase 2, Recruiting
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
for
Advanced/Metastatic Solid Tumors, Bladder Cancer,
Location: Irvine CA, Duarte CA, San Antonio TX, Conroe TX,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07090499
Phase 1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
for
Ovarian Neoplasms, Fallopian Tube Neoplasms,
Location: Irvine CA, Duarte CA, Los Angeles CA, Burbank CA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07213804
Phase 3, Recruiting
Testing the Effectiveness of the Anti-cancer Drug, Mirdametinib, in Treating Relapsed, Refractory Chronic Lymphocytic Leukemia
for
Recurrent Chronic Lymphocytic Leukemia,
Location: Irvine CA, Duarte CA, Sacramento CA, Salt Lake City UT,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT07061951
Phase 2, Recruiting
A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular Atrophy
for
Spinal Muscular Atrophy, SMA, Spinal Muscular Atrophy Type 2,
Location: Orange CA, Phoenix AZ, Palo Alto CA, Aurora CO,
Sponsor: Scholar Rock, Inc.
Sex: All
Age: 0 - 2
Code: NCT07047144
Phase 2, Recruiting
Venetoclax and Obinutuzumab Followed by Epcoritamab for the Treatment of Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma, LonGEVity Trial
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Irvine CA, Long Beach CA, Duarte CA, Newnan GA
Sponsor: City of Hope Medical Center
Sex: All
Age: 18+
Code: NCT07218510
Phase 2, Recruiting
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
for
Non-small Cell Lung Cancer
Location: Irvine CA, Duarte CA, Phoenix AZ, Grand Junction CO,
Sponsor: Canadian Cancer Trials Group
Sex: All
Age: 18+
Code: NCT06686771
Phase 3, Recruiting
A Multicenter Prospective Observational Cohort Study Evaluating the Impact of Cancer-Directed Treatment and Medication Use, Including Cannabis Use, in Multiple Myeloma Patients
for
Multiple Myeloma
Location: Irvine CA, Duarte CA
Sponsor: City of Hope Medical Center
Sex: All
Age: 18+
Code: NCT07225738
Recruiting
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: Irvine CA, Duarte CA, Los Angeles CA, Phoenix AZ,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07258511
Phase 3, Recruiting
AMG 436 as Monotherapy and Combination Therapy in Participants With MSI-H/dMMR Solid Tumors
for
Metastatic or Locally Advanced Solid Tumors With Microsatellite Instability-high (MSI-H) or Mismatched Repair Deficiency (dMMR),
Location: Irvine CA, Newport Beach CA, Irving TX, Zion IL,
Sponsor: Amgen
Sex: All
Age: 18 - 70+
Code: NCT07403721
Phase 1, Recruiting
Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma
Location: Irvine CA, Tucson AZ, Nampa ID, Meridian ID, Boise ID,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT04840602
Phase 2, Recruiting
A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
for
Non Small Cell Lung Cancer, Advanced Non Small Cell Lung Cancer,
Location: Irvine CA, Goodyear AZ, Temple TX, Houston TX,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07154290
Phase 2, Recruiting
Study of GB-4362 With Enfortumab Vedotin and Pembrolizumab for Advanced Urothelial Cancer